IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

ScinoPharm Signs API Manufacturing Deal with Clinical Data

11:38 PM MST | February 14, 2011 | Deepti Ramesh

Active pharmaceutical ingredients (APIs) manufacturer and contract research and manufacturing services (CRAMS) company ScinoPharm (Shan-Hua, Taiwan) says it will provide commercial manufacturing service for vilazodone hydrochloride API for Clinical Data’s (Newton, MA) Viibryd. Viibryd is a new drug entity recently approved by the U.S. Food and Drug Administration for the treatment of major depressive disorder in adults. ScinoPharm says it is set to expand its CRAM services through its new plant at Changshu, China, which is expected to be operational in the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa